Cover Image
市場調查報告書

睪酮(睪丸激素)替代療法市場 - 全球產業分析,規模,佔有率,成長,趨勢及預測

Testosterone Replacement Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

出版商 Transparency Market Research 商品編碼 367370
出版日期 內容資訊 英文 127 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
睪酮(睪丸激素)替代療法市場 - 全球產業分析,規模,佔有率,成長,趨勢及預測 Testosterone Replacement Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024
出版日期: 2016年07月11日 內容資訊: 英文 127 Pages
簡介

含有各種活性成分的廣泛睪酮(睪丸激素)替代療法產品變得可利用。可是該市場,由於今後數年主要產品的專利失效,而處於嚴峻的狀況。收益明顯大幅度減少。

本報告提供全球睪酮(睪丸激素)替代療法市場相關調查,市場現狀及未來發展預測,各產品,地區趨勢,參與企業簡介等彙整資料。

第1章 序論

第2章 摘要整理

第3章 產業分析

  • 簡介
  • 市場趨勢
    • 促進要素
      • 睪固酮缺乏症的發病率上升
      • 有睪固酮缺乏症的高風險的老年人增加
      • 睪酮(睪丸激素)替代療法相關的意識提升
    • 阻礙要素
      • 睪酮(睪丸激素)替代療法相關副作用的高風險
      • 主要藥物的專利失效和非專利的進入
    • 機會
      • 亞太地區大的可能性
  • 市場魅力度分析
  • 價格分析
  • 市場收益:各產品
  • 市場收益:各活性成分
  • 競爭環境
  • 開發平台分析
  • 開發時間軸

第4章 北美市場分析

  • 主要趨勢
  • 各產品市場收益
  • 各活性成分市場收益

第5章 歐洲市場分析

  • 主要趨勢
  • 各產品市場收益
  • 各活性成分市場收益

第6章 亞太地區市場分析

  • 主要趨勢
  • 各產品市場收益
  • 各活性成分市場收益

第7章 中東市場分析

  • 主要趨勢
  • 各產品市場收益
  • 各活性成分市場收益

第8章 南美市場分析

  • 主要趨勢
  • 各產品市場收益
  • 各活性成分市場收益

第9章 各國概要

第10章 企業簡介

  • AbbVie, Inc.
  • Allergan plc
  • Bayer AG
  • Endo Pharmaceuticals, Inc.
  • Eli Lilly and Company
  • Kyowa Kirin International plc
  • Mylan N.V.
  • Novartis AG
  • Pfizer, Inc.

圖表

目錄

Patent Expiry Blow Dealt to TRT Market Could be Softened by Growing Prevalence of Hypogonadism

A wide range of testosterone replacement therapy (TRT) products containing different active ingredients have been made available by a large number of both global and local manufacturers. With various studies estimating the number of men affected by hypogonadism (testosterone deficiency) at 30% worldwide, the demand for TRT is poised to increase gradually in the years ahead. The condition primarily affects men aged between 40 and 79 years, making this demographic a key target segment for market players.

However, the market is currently at a crucial juncture with top performing products losing their patents in the next few years. This will no doubt cause a major dent in revenues of key market players. However, some of this impact could be reduced by the heightened demand for and awareness levels about the benefits of advanced TRT products. Many of these products are now being utilized in testosterone deficiency treatment are likely to support market growth during the forecast period.

image1

TRT Creams and Gels Continue to See Strong Sales Worldwide but Injections Racing Ahead

For the purpose of this study, the global testosterone replacement therapy market has been segmented on the basis of product type into creams/gels, patches, injections, gums/buccal adhesives, implants and oral drug forms. Of these, the creams/gels segment led the global market, as overall sales were mainly impelled by key branded formulations such as AndroGel from AbbVie, Inc. Axiron from Eli Lilly and Company, and Fortesta, Testim, and Natesto from Endo Pharmaceuticals Inc.

Ease of use and comparatively less side effects have been the winning characteristics of gels/cream TRT products. However, this segment is expected to lose its current hold on the market owing to patent expirations of branded formulations.

TMR expects the injections product segment to witness the fastest CAGR from 2016 to 2024. This will be possible mainly because consumers are now more open to using these low priced products - a factor aided by the increasing availability of self-administered forms of these products globally.

On the basis of active ingredients, the TRT market is segmented into testosterone, methyl testosterone, testosterone undecanoate, and testosterone enanthate and testosterone cypionate. Of these, testosterone as an active ingredient dominated the global TRT market in 2015. However, other active ingredients are expected to cover much ground through the forecast period. The demand for ester forms of testosterone such as testosterone cypionate and testosterone undecanoate is projected to show a healthy rise. Testosterone undecanoate is expected to witness the fastest growth through the report's forecasting horizon from 2016 to 2024.

North America Leads TRT Market but Scales Tipping in Favor of Asia Pacific

Of the five broad geographical segments of the global testosterone replacement therapy market, North America accounted for the largest share (84.7%) of the market and was followed by Europe In 2015. The other key segments are Europe, Asia Pacific, Middle East and Africa (MEA), and Latin America.

The demand for advanced TRT products was especially strong in the U.S. in 2015 as the country accounted for 95% of the North America TRT market in that year, TMR has observed. Asia Pacific will greatly benefit from higher healthcare investments being channeled into the region and is expected to witness the fastest CAGR in the TRT market during the forecast period. China and India are markets that companies in the TRT market cannot ignore. In South Korea and Japan, on the other hand, the sizeable geriatric population and strong positive sentiments will aid the consumption of TRT products. Brazil is the key TRT market in Latin America with the single largest share 2015.

The key players operating in the global testosterone replacement therapy market are AbbVie, Inc., Allergan plc, Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Mylan N.V., Novartis AG, and Pfizer, Inc. The testosterone replacement therapy market is somewhat consolidated with presence of a few large global players and some local vendors that are operating in the international market.

Report Description

This report on testosterone replacement therapy studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various testosterone replacement therapy products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered within the scope of the study. This section also provides the overall information and data analysis of the global testosterone replacement therapy (TRT) market with respect to the leading market segments based on major products, key active ingredients and geographies.

The global testosterone replacement therapy market has been studied based on major TRT product segments, active ingredient segments, and their regional as well as national markets. Based on product type, the global market has been categorized into six major segments: creams/gels, patches, injections, gums/buccal adhesives, implants and oral. Based on active ingredient type, the global market has been categorized into five major segments: testosterone, methyl testosterone, testosterone undecanoate, and testosterone enanthate and testosterone cypionate. The market for these segments has been extensively analyzed based on their utility, effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn for the period from 2014 to 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all segments, considering 2015 as the base year.

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the global testosterone replacement therapy market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market. Geographically, the testosterone replacement therapy market has been segmented into five regions: North America, Europe, Asia Pacific, Middle East and Africa (MEA) and Latin America. Each regional market for testosterone replacement therapy has been further categorized into major product and active ingredient segments considered within the scope of the study. Key country (U.S., Japan, Germany, U.K., Canada, China, Brazil, Mexico and UAE) market revenues have also been provided in a separate country snippets chapter of the report. Market revenue in terms of US$ Mn for the period from 2014 to 2024 along with CAGR % from 2016 to 2024 are provided for all the regions and nations considering 2015 as the base year.

The report also profiles key players operating in the testosterone replacement therapy market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include AbbVie, Inc., Allergan plc, Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Mylan N.V., Novartis AG, and Pfizer, Inc.

The global testosterone replacement therapy market is segmented as follows:

Global Testosterone Replacement Therapy Market, by Product Type

  • Creams/Gels
  • Patches
  • Injections
  • Gums/Buccal Adhesives
  • Implants
  • Oral

Global Testosterone Replacement Therapy Market, by Active Ingredient Type

  • Testosterone
  • Methyl Testosterone
  • Testosterone Undecanoate
  • Testosterone Enanthate
  • Testosterone Cypionate

Global Testosterone Replacement Therapy Market, by Geography

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Global Testosterone Replacement Therapy Market, Country Snippets

  • U.S.
  • Japan
  • Germany
  • U.K.
  • Canada
  • China
  • Brazil
  • Mexico
  • UAE

Table of Contents

1. Preface

  • 1.1. Report Description
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

  • 2.1. Global Testosterone Replacement Therapy: Market Snapshot
  • 2.2. Global Testosterone Replacement Therapy Market Share, by Geography, 2015 & 2024 (E)
  • 2.3. Global Testosterone Replacement Therapy Market Revenue, by Product Type, (US$ Mn), 2015
  • 2.4. Global Testosterone Replacement Therapy Market Revenue, by Active Ingredient, (US$ Mn), 2015

3. Global Testosterone Replacement Therapy Market - Industry Analysis

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers
      • 3.2.1.1. Increase in incidence of testosterone deficiency
      • 3.2.1.2. Rise in geriatric population with high risk of testosterone deficiency
      • 3.2.1.3. Growing awareness about testosterone replacement therapy
    • 3.2.2. Restraints
      • 3.2.2.1. High risk of side effects related to testosterone replacement therapy
      • 3.2.2.2. Patent expiry of key drugs and entry of generics
    • 3.2.3. Opportunities
      • 3.2.3.1. Asia Pacific holds immense potential for testosterone replacement therapy
  • 3.3. Market Attractiveness Analysis: Global Testosterone Replacement Therapy Market, by Geography, 2015
  • 3.4. Pricing Analysis: Testosterone Replacement Therapy Market, by Product, (US$) 2015
  • 3.5. Global Testosterone Replacement Therapy Market Revenue, by Product Type, (US$ Mn), 2014-2024
    • 3.5.1. Overview
    • 3.5.2. Global Creams/Gels Market Revenue, (US$ Mn), 2014-2024
    • 3.5.3. Global Patches Market Revenue, (US$ Mn), 2014-2024
    • 3.5.4. Global Injections Market Revenue, (US$ Mn), 2014-2024
    • 3.5.5. Global Gums/Buccal Adhesives Market Revenue, (US$ Mn), 2014-2024
    • 3.5.6. Global Implants Market Revenue, (US$ Mn), 2014-2024
    • 3.5.7. Global Oral TRT Market Revenue, (US$ Mn), 2014-2024
  • 3.6. Global Testosterone Replacement Therapy Market Revenue, By Active Ingredient, (US$ Mn), 2014-2024
    • 3.6.1. Overview
    • 3.6.2. Global Testosterone Market Revenue, (US$ Mn) 2014-2024
    • 3.6.3. Global Methyl Testosterone Market Revenue, (US$ Mn) 2014-2024
    • 3.6.4. Global Testosterone Undecanoate Market Revenue, (US$ Mn) 2014-2024
    • 3.6.5. Global Testosterone Enanthate Market Revenue, (US$ Mn) 2014-2024
    • 3.6.6. Global Testosterone Cypionate Market Revenue, (US$ Mn) 2014-2024
  • 3.7. Competitive Landscape: Global Testosterone Replacement Therapy Market Share, by Key Players, 2015 (%)
  • 3.8. Pipeline Analysis: Testosterone Replacement Therapy
  • 3.9. TRT Technology Development Timeline

4. North America Testosterone Replacement Therapy Market Analysis

  • 4.1. Key Trends Analysis
  • 4.2. North America Testosterone Replacement Therapy (TRT) Market Revenue, by Product Type, (US$ Mn), 2014-2024
  • 4.3. North America Testosterone Replacement Therapy (TRT) Market Revenue, by Active Ingredient, (US$ Mn), 2014-2024

5. Europe Testosterone Replacement Therapy Market Analysis

  • 5.1. Key Trends Analysis
  • 5.2. Europe Testosterone Replacement Therapy (TRT) Market Revenue, by Product Type, (US$ Mn), 2014-2024
  • 5.3. Europe Testosterone Replacement Therapy (TRT) Market Revenue, by Active Ingredient, (US$ Mn), 2014-2024

6. Asia Pacific Testosterone Replacement Therapy Market Analysis

  • 6.1. Key Trends Analysis
  • 6.2. Asia Pacific Testosterone Replacement Therapy (TRT) Market Revenue, by Product Type, (US$ Mn), 2014-2024
  • 6.3. Asia Pacific Testosterone Replacement Therapy (TRT) Market Revenue, by Active Ingredient, (US$ Mn), 2014-2024

7. Middle East and Africa (MEA) Testosterone Replacement Therapy Market Analysis

  • 7.1. Key Trends Analysis
  • 7.2. MEA Testosterone Replacement Therapy (TRT) Market Revenue, by Product Type, (US$ Mn), 2014-2024
  • 7.3. MEA Testosterone Replacement Therapy (TRT) Market Revenue, by Active Ingredient, (US$ Mn), 2014-2024

8. Latin America Testosterone Replacement Therapy Market Analysis

  • 8.1. Key Trends Analysis
  • 8.2. Latin America Testosterone Replacement Therapy (TRT) Market Revenue, by Product Type, (US$ Mn), 2014-2024
  • 8.3. Latin America Testosterone Replacement Therapy (TRT) Market Revenue, by Active Ingredient, (US$ Mn), 2014-2024

9. Global Testosterone Replacement Therapy Market, Country Snippets

  • 9.1. Global Testosterone Replacement Therapy Market Revenue, by Country, (US$ Mn), 2014-2024
  • 9.2. U.S. Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014-2024
  • 9.3. Japan Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014-2024
  • 9.4. Germany Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014-2024
  • 9.5. U.K. Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014-2024
  • 9.6. Canada Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014-2024
  • 9.7. China Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014-2024
  • 9.8. Brazil Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014-2024
  • 9.9. Mexico Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014-2024
  • 9.10. United Arab Emirates (UAE) Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014-2024

10. Company Profiles

  • 10.1. AbbVie, Inc.
  • 10.2. Allergan plc
  • 10.3. Bayer AG
  • 10.4. Endo Pharmaceuticals, Inc.
  • 10.5. Eli Lilly and Company
  • 10.6. Kyowa Kirin International plc
  • 10.7. Mylan N.V.
  • 10.8. Novartis AG
  • 10.9. Pfizer, Inc.

List of Figures

  • Figure 1: Market Segmentation
  • Figure 2: Global Testosterone Replacement Therapy Market Share, by Geography, 2015
  • Figure 3: Global Testosterone Replacement Therapy Market Share, by Geography, 2024 (E)
  • Figure 4: Global Testosterone Replacement Therapy Market Revenue, by Product Type, (US$ Mn), 2015
  • Figure 5: Global Testosterone Replacement Therapy Market Revenue, by Active Ingredient, (US$ Mn), 2015
  • Figure 6: Global Testosterone Replacement Therapy Market, by Geography, 2015
  • Figure 7: Global Creams/Gels Market Revenue, (US$ Mn), 2014-2024
  • Figure 8: Global Patches Market Revenue, (US$ Mn), 2014-2024
  • Figure 9: Global Injections Market Revenue, (US$ Mn), 2014-2024
  • Figure 10: Global Gums/Buccal Adhesives Market Revenue, (US$ Mn), 2014-2024
  • Figure 11: Global Implants Market Revenue, (US$ Mn), 2014-2024
  • Figure 12: Global Oral TRT Market Revenue, (US$ Mn), 2014-2024
  • Figure 13: Global Testosterone Market Revenue, (US$ Mn), 2014-2024
  • Figure 14: Global Methyl Testosterone Market Revenue, (US$ Mn) 2014-2024
  • Figure 15: Global Testosterone Undecanoate Market Revenue, (US$ Mn), 2014-2024
  • Figure 16: Global Testosterone Enanthate Market Revenue, (US$ Mn), 2014-2024
  • Figure 17: Global Testosterone Cypionate Market Revenue, (US$ Mn), 2014-2024
  • Figure 18: Global Testosterone Replacement Therapy Market Share, by Key Players, 2015 (%)
  • Figure 19: North America TRT Market, by Product Type, (US$ Mn), 2014-2024
  • Figure 20: North America TRT Market, By Product Type, 2015
  • Figure 21: North America TRT Market, By Product Type, 2024 (E)
  • Figure 22: North America TRT Market, by Active Ingredient (US$ Mn), 2014-2024
  • Figure 23: North America TRT Market, By Active Ingredient, 2015
  • Figure 24: North America TRT Market, By Active Ingredient, 2024 (E)
  • Figure 25: Europe TRT Market, by Product Type (US$ Mn), 2014-2024
  • Figure 26: Europe TRT Market, By Product Type, 2015
  • Figure 27: Europe TRT Market, By Product Type, 2024 (E)
  • Figure 28: Europe TRT Market, by Active Ingredient, (US$ Mn), 2014-2024
  • Figure 29: Europe TRT Market, By Active Ingredient, 2015
  • Figure 30: Europe TRT Market, By Active Ingredient, 2024 (E)
  • Figure 31: Asia Pacific TRT Market, by Product Type, (US$ Mn), 2014-2024
  • Figure 32: Asia Pacific TRT Market, by Product Type, 2015
  • Figure 33: Asia Pacific TRT Market, by Product Type, 2024 (E)
  • Figure 34: Asia Pacific TRT Market, by Active Ingredient (US$ Mn), 2014-2024
  • Figure 35: Asia Pacific TRT Market, by Active Ingredient, 2015
  • Figure 36: Asia Pacific TRT Market, by Active Ingredient, 2024 (E)
  • Figure 37: MEA TRT Market Share, By Product Type, 2015
  • Figure 39: MEA TRT Market, by Product (US$ Mn), 2014-2024
  • Figure 38: MEA TRT Market Share, By Product Type, 2024 (E)
  • Figure 40: MEA TRT Market Share, By Active Ingredient, 2015
  • Figure 42: MEA TRT Market, by Active Ingredient (US$ Mn), 2014-2024
  • Figure 41: MEA TRT Market Share, By Active Ingredient, 2024 (E)
  • Figure 43: Latin America TRT Market, by Product Type, 2015
  • Figure 45: Latin America TRT Market, by Product Type (US$ Mn), 2014-2024
  • Figure 44: Latin America TRT Market, by Product Type, 2024 (E)
  • Figure 46: Latin America TRT Market, by Active Ingredient, 2015
  • Figure 48: Latin America TRT Market, by Active Ingredient (US$ Mn), 2014-2024
  • Figure 47: Latin America TRT Market, by Active Ingredient, 2024 (E)
  • Figure 49: U.S. Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014-2024
  • Figure 50: Japan Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014-2024
  • Figure 51: Germany Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014-2024
  • Figure 52: U.K. Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014-2024
  • Figure 53: Canada Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014-2024
  • Figure 54: China Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014-2024
  • Figure 55: Brazil Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014-2024
  • Figure 56: Mexico Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014-2024
  • Figure 57: UAE Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014-2024

List of Tables

  • TABLE 1 Global Testosterone Replacement Therapy: Market Snapshot
  • TABLE 2 Pricing Analysis, by Product, (US$) 2015
  • TABLE 3 Global Testosterone Replacement Therapy Market Revenue, by Product Type, (US$ Mn), 2014-2024
  • TABLE 4 Global Testosterone Replacement Therapy Market Revenue, By Active Ingredient, (US$ Mn), 2014-2024
  • TABLE 5 Pipeline Analysis - Testosterone Replacement Therapy
  • TABLE 6 TRT Technology Development Timeline
  • TABLE 7 North America Testosterone Replacement Therapy (TRT) Market Revenue, by Product Type, (US$ Mn), 2014-2024
  • TABLE 8 North America Testosterone Replacement Therapy (TRT) Market Revenue, by Active Ingredient, (US$ Mn), 2014-2024
  • TABLE 9 Europe Testosterone Replacement Therapy (TRT) Market Revenue, by Product Type, (US$ Mn), 2014-2024
  • TABLE 10 Europe Testosterone Replacement Therapy (TRT) Market Revenue, by Active Ingredient, (US$ Mn), 2014-2024
  • TABLE 11 Asia Pacific Testosterone Replacement Therapy (TRT) Market Revenue, by Product Type, (US$ Mn), 2014-2024
  • TABLE 12 Asia Pacific Testosterone Replacement Therapy (TRT) Market Revenue, by Active Ingredient, (US$ Mn), 2014-2024
  • TABLE 13 MEA Testosterone Replacement Therapy (TRT) Market Revenue, by Product Type, (US$ Mn), 2014-2024
  • TABLE 14 MEA Testosterone Replacement Therapy (TRT) Market Revenue, by Active Ingredient, (US$ Mn), 2014-2024
  • TABLE 15 Latin America Testosterone Replacement Therapy (TRT) Market Revenue, by Product Type, (US$ Mn), 2014-2024
  • TABLE 16 Latin America Testosterone Replacement Therapy (TRT) Market Revenue, by Active Ingredient, (US$ Mn), 2014-2024
  • TABLE 17 Global Testosterone Replacement Therapy Market Revenue, by Country, (US$ Mn), 2014-2024
Back to Top